Ibrutinib (Imbruvica®) for cGVHD.

Autor: Melaragno, Adam
Zdroj: Oncology Times; 9/20/2018, Vol. 40 Issue 18, p12-12, 1p
Databáze: Supplemental Index
Externí odkaz: